GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Edesa Biotech Inc (NAS:EDSA) » Definitions » E10

Edesa Biotech (Edesa Biotech) E10 : $-85.87 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Edesa Biotech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Edesa Biotech's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.580. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-85.87 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Edesa Biotech was 25.30% per year. The lowest was 10.30% per year. And the median was 17.80% per year.

As of today (2024-05-24), Edesa Biotech's current stock price is $4.60. Edesa Biotech's E10 for the quarter that ended in Mar. 2024 was $-85.87. Edesa Biotech's Shiller PE Ratio of today is .


Edesa Biotech E10 Historical Data

The historical data trend for Edesa Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edesa Biotech E10 Chart

Edesa Biotech Annual Data
Trend Aug14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -297.00 -279.60 -244.99 -214.64 -116.56

Edesa Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -184.93 -179.75 -116.56 -86.20 -85.87

Competitive Comparison of Edesa Biotech's E10

For the Biotechnology subindustry, Edesa Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edesa Biotech's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Edesa Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Edesa Biotech's Shiller PE Ratio falls into.



Edesa Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edesa Biotech's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.58/126.2576*126.2576
=-0.580

Current CPI (Mar. 2024) = 126.2576.

Edesa Biotech Quarterly Data

per share eps CPI Adj_EPS
201405 58.800 99.394 74.692
201408 -179.340 99.315 -227.992
201412 -49.980 98.367 -64.151
201503 -14.700 99.789 -18.599
201506 14.700 100.500 18.467
201509 -58.800 100.421 -73.928
201512 -55.860 99.947 -70.565
201603 -29.400 101.054 -36.733
201606 -41.160 102.002 -50.948
201609 -38.220 101.765 -47.419
201612 -44.100 101.449 -54.885
201703 -31.930 102.634 -39.280
201706 -35.280 103.029 -43.234
201709 -34.020 103.345 -41.563
201712 -39.060 103.345 -47.720
201803 -37.800 105.004 -45.451
201806 -15.960 105.557 -19.090
201809 -8.895 105.636 -10.631
201812 -10.920 105.399 -13.081
201903 -13.020 106.979 -15.366
201906 -2.100 107.690 -2.462
201909 -0.890 107.611 -1.044
201912 -1.050 107.769 -1.230
202003 -1.190 107.927 -1.392
202006 -1.400 108.401 -1.631
202009 -1.540 108.164 -1.798
202012 -1.820 108.559 -2.117
202103 -1.330 110.298 -1.522
202106 -2.520 111.720 -2.848
202109 -1.890 112.905 -2.114
202112 -2.310 113.774 -2.563
202203 -2.310 117.646 -2.479
202206 -2.590 120.806 -2.707
202209 -1.090 120.648 -1.141
202212 -0.890 120.964 -0.929
202303 -0.820 122.702 -0.844
202306 -0.700 124.203 -0.712
202309 -0.559 125.230 -0.564
202312 -0.540 125.072 -0.545
202403 -0.580 126.258 -0.580

Add all the adjusted EPS together and divide 10 will get our e10.


Edesa Biotech  (NAS:EDSA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Edesa Biotech E10 Related Terms

Thank you for viewing the detailed overview of Edesa Biotech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Edesa Biotech (Edesa Biotech) Business Description

Traded in Other Exchanges
N/A
Address
100 Spy Court, Markham, ON, CAN, L3R 5H6
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Executives
Stephen Lemieux officer: Chief Financial Officer 100 SPY COURT, C/O EDESA BIOTECH, INC., MARKHAM A6 L3R 5H6
Joan Chypyha director 100 SPY COURT, MARKHAM A6 L3R 5H6
Patrick Marshall director 100 SPY COURT, MARKHAM A6 L3R 5H6
Van Der Velden Peter director, 10 percent owner C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM A6 L3R 5H6
Michael J Brooks officer: President C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM A6 L3R 5H6
Pardeep Nijhawan director, 10 percent owner, officer: Chief Executive Officer C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM A6 L3R 5H6
Jennifer M Chao director 7 PURITAN WOODS ROAD, RYE NY 10580
Frank R. Oakes director, officer: President, CEO, & Director C/O STELLAR BIOTECHNOLOGIES, INC., 332 EAST SCOTT STREET, PORT HUENEME CA 93041
Sean Arthur Macdonald director C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM A6 L3R 5H6
Lorin K Johnson director 3600 W BAYSHORE ROAD SUITE 205, PALO ALTO CA 94303
Pardeep Nijhawan Medicine Professional Corp 10 percent owner C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM A6 L3R 5H6
Paul William Pay director C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM A6 L3R 5H6
Carlo Sistilli director C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM A6 L3R 5H6
Lumira Capital Investment Management Inc. 10 percent owner 141 ADELAIDE STREET WEST, SUITE 770, TORONTO A6 M5H 3L5
Daniel E. Morse director C/O STELLAR BIOTECHNOLOGIES, INC., 332 EAST SCOTT STREET, PORT HUENEME CA 93041